Zinlistiq Trademark Details

This mark is alive with a status of Fifth Extension - Granted. The last case file activity for this mark occured 7 years ago on Thursday, September 29, 2016, according to the United State Patent & Trademark Office

Word Mark	Zinlistiq
Status	Alive 734 — Fifth Extension - Granted

Current Owner

Eli Lilly and Company of Indianapolis, IN

View all trademarks for Eli Lilly and Company

Other Trademarks for Eli Lilly and Company

Serial Number	85864154
Status Date	Thursday, September 29, 2016
Filing Date	Thursday, September 29, 2016
Attorney	Robert E. Lee, Jr.

Correspondent

ROBERT E. LEE, JR.
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285-0001

Case File Statements

Goods & Services	Pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders; pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders; pharmaceutical preparations for the treatment of diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines; pharmaceutical preparations for the treatment of muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders; sleep disorders and urological disorders; antidepressants

Pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders; pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders; pharmaceutical preparations for the treatment of diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines; pharmaceutical preparations for the treatment of muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders; sleep disorders and urological disorders; antidepressants

Classifications

International Class Codes	005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes	006, 018, 044, 046, 051, 052
Status	6 — Active
Status Date	Thursday, March 7, 2013
Primary Code	005

Trademark Timeline

Mar 01 2013

Trademark application filed with USPTO
Mar 05 2013

New Application Entered In Tram
Mar 07 2013

New Application Office Supplied Data Entered In Tram
Jun 13 2013

Notification of Non-Final Action E-Mailed
Jun 13 2013

Non-Final Action E-Mailed
Jun 13 2013

Non-Final Action Written
Jun 13 2013

Assigned To Examiner
Dec 04 2013

Correspondence Received In Law Office
Dec 04 2013

Teas Response To Office Action Received
Dec 05 2013

Approved For Pub - Principal Register
Dec 05 2013

Teas/email Correspondence Entered
Jan 02 2014

Assigned To Lie
Jan 03 2014

Law Office Publication Review Completed
Jan 22 2014

Notification of Notice of Publication E-Mailed
Feb 11 2014

Official Gazette Publication Confirmation E-Mailed
Feb 11 2014

Published For Opposition
Apr 08 2014

Noa E-Mailed - Sou Required From Applicant
Sep 23 2014

Extension 1 Granted
Sep 23 2014

Extension 1 Filed
Sep 23 2014

Teas Extension Received
Sep 25 2014

Notice of Approval of Extension Request E-Mailed
Mar 20 2015

Extension 2 Filed
Mar 20 2015

Teas Extension Received
Apr 27 2015

Case Assigned To Intent To Use Paralegal
Apr 29 2015

Extension 2 Granted
Apr 30 2015

Notice of Approval of Extension Request E-Mailed
Sep 25 2015

Extension 3 Filed
Sep 25 2015

Teas Extension Received
Sep 29 2015

Extension 3 Granted
Sep 30 2015

Notice of Approval of Extension Request E-Mailed
Jan 26 2016

Extension 4 Filed
Jan 26 2016

Teas Extension Received
Feb 22 2016

Extension 4 Granted
Feb 23 2016

Notice of Approval of Extension Request E-Mailed
Sep 23 2016

Extension 5 Filed
Sep 23 2016

Teas Extension Received
Sep 29 2016

Extension 5 Granted
Sep 30 2016

Notice of Approval of Extension Request E-Mailed